Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to investigate whether Hi-tACS is effective and safe in treating negative symptoms of schizophrenia. Schizophrenic patients will receive treatment (Hi-tACS or shame...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Shanghai Mental Health Center
NCT06127056 · Transcranial Alternating Current Stimulation, Non-suicidal Self-injury
NCT06026826 · Transcranial Alternating Current Stimulation, Anxiety Disorder, and more
NCT02505477 · Schizophrenia, Cognitive Deficits, and more
NCT05809076 · Transcranial Alternating Current Stimulation
NCT05312359 · Substance Dependence, Executive Function Disorder, and more
Shanghai Mental Health Center
Shanghai, Shanghai Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions